BULLOUS PEMPHIGOID (BP)

Clinical trials for BULLOUS PEMPHIGOID (BP) explained in plain language.

Never miss a new study

Get alerted when new BULLOUS PEMPHIGOID (BP) trials appear

Sign up with your email to follow new studies for BULLOUS PEMPHIGOID (BP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

New drug RAY121 shows promise for controlling rare immune disorders

Disease control ENROLLING_BY_INVITATION

This study tests a drug called RAY121 in people with certain immune system diseases, such as antiphospholipid syndrome and immune thrombocytopenia. The goal is to see if long-term use can safely control these conditions. Participants must have already responded to RAY121 in a pre…

Matched conditions: BULLOUS PEMPHIGOID (BP)

Phase: PHASE1 • Sponsor: Chugai Pharmaceutical • Aim: Disease control

Last updated May 22, 2026 13:53 UTC

BULLOUS PEMPHIGOID (BP)

Get alerted when new BULLOUS PEMPHIGOID (BP) trials appear

New drug RAY121 shows promise for controlling rare immune disorders